Stocks have been on a tear. The S & P 500 is soaring to record highs this year and the Dow Jones Industrial Average just had its best week of the year — and its eighth-straight winning session last Friday. Investors will look to the upcoming inflation prints for more clues as to when the U.S. Federal Reserve will cut rates. However, earnings so far have helped stocks stay resilient.
Pro scoured Goldman's May conviction lists for stocks with further upside of 50% or more, based on the bank's price targets. Quanterix : Goldman described the company as a pure-play neurology diagnostics company with "leading exposure" to the Alzheimer's disease blood-based diagnostics opportunity. Goldman gave it a price target of $35, implying 107% upside.
's Michael Bloom contributed to this report.